Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections

Tuberculosis (TB) causes millions of deaths every year, ranking as one of the most dangerous infectious diseases worldwide. Because several pathogenic strains of M. tuberculosis (Mtb) have developed resistance against most of the established anti-TB drugs, new therapeutic options are urgently needed...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Matteo, Stelitano, Giovanni, Griego, Anna, Chiarelli, Laurent R., Cazzaniga, Giulia, Gelain, Arianna, Pini, Elena, Camera, Marina, Canzano, Paola, Fumagalli, Andrea, Scarpa, Edoardo, Cordiglieri, Chiara, Rizzello, Loris, Villa, Stefania, Meneghetti, Fiorella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413995/
https://www.ncbi.nlm.nih.gov/pubmed/36015139
http://dx.doi.org/10.3390/ph15080992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413995/
https://www.ncbi.nlm.nih.gov/pubmed/36015139
http://dx.doi.org/10.3390/ph15080992

Ejemplares similares